{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:16:40Z","timestamp":1780345000388,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/onc.2015.208","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T14:07:24Z","timestamp":1436191644000},"page":"1433-1444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance"],"prefix":"10.1038","volume":"35","author":[{"given":"U","family":"Karunarathna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kongsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Zona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A R","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E P S","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Khongkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W-H","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U-S","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H","family":"Medema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E W-F","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"BFonc2015208_CR1","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1200\/JCO.1997.15.8.2981","volume":"15","author":"DM Savarese","year":"1997","unstructured":"Savarese DM, Hsieh C, Stewart FM . Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors. J Clin Oncol 1997; 15: 2981\u20132995.","journal-title":"J Clin Oncol"},{"key":"BFonc2015208_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrc2223","volume":"7","author":"SS Myatt","year":"2007","unstructured":"Myatt SS, Lam EW . The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007; 7: 847\u2013859.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015208_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrc2223-c2","volume":"8","author":"SS Myatt","year":"2008","unstructured":"Myatt SS, Lam EW . Targeting FOXM1. Nat Rev Cancer 2008; 8: 242.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015208_CR4","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1158\/1535-7163.MCT-08-0188","volume":"7","author":"JM Kwok","year":"2008","unstructured":"Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW . Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther 2008; 7: 2022\u20132032.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2015208_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1158\/1541-7786.MCR-09-0432","volume":"8","author":"JM Kwok","year":"2010","unstructured":"Kwok JM, Peck B, Monteiro LJ, Schwenen HD, Millour J, Coombes RC et al. FOXM1 confers acquired cisplatin resistance in breast cancer cells. Mol Cancer Res 2010; 8: 24\u201334.","journal-title":"Mol Cancer Res"},{"key":"BFonc2015208_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/1535-7163.MCT-08-0805","volume":"8","author":"UB McGovern","year":"2009","unstructured":"McGovern UB, Francis RE, Peck B, Guest SK, Wang J, Myatt SS et al. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther 2009; 8: 582\u2013591.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2015208_CR7","unstructured":"Khongkow P, Gomes AR, Gong C, Man EP, Tsang JW, Zhao F et al. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene e-pub ahead of print 11 May 2015; 34; doi:10.1038\/onc.2015.1152."},{"key":"BFonc2015208_CR8","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1038\/onc.2012.491","volume":"32","author":"LJ Monteiro","year":"2013","unstructured":"Monteiro LJ, Khongkow P, Kongsema M, Morris JR, Man C, Weekes D et al. The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment. Oncogene 2013; 32: 4634\u20134645.","journal-title":"Oncogene"},{"key":"BFonc2015208_CR9","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1038\/onc.2013.457","volume":"33","author":"P Khongkow","year":"2014","unstructured":"Khongkow P, Karunarathna U, Khongkow M, Gong C, Gomes AR, Yague E et al. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene 2014; 33: 4144\u20134155.","journal-title":"Oncogene"},{"key":"BFonc2015208_CR10","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1038\/onc.2013.546","volume":"33","author":"SS Myatt","year":"2014","unstructured":"Myatt SS, Kongsema M, Man CW, Kelly DJ, Gomes AR, Khongkow P et al. SUMOylation inhibits FOXM1 activity and delays mitotic transition. Oncogene 2014; 33: 4316\u20134329.","journal-title":"Oncogene"},{"key":"BFonc2015208_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.breast.2011.12.012","volume":"21","author":"M Khasraw","year":"2012","unstructured":"Khasraw M, Bell R, Dang C . Epirubicin: is it like doxorubicin in breast cancer? A clinical review. Breast 2012; 21: 142\u2013149.","journal-title":"Breast"},{"key":"BFonc2015208_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/1535-7163.MCT-11-0024","volume":"10","author":"J Millour","year":"2011","unstructured":"Millour J, de Olano N, Horimoto Y, Monteiro LJ, Langer JK, Aligue R et al. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance. Mol Cancer Ther 2011; 10: 1046\u20131058.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2015208_CR13","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/1541-7786.MCR-11-0559","volume":"10","author":"N de Olano","year":"2012","unstructured":"de Olano N, Koo CY, Monteiro LJ, Pinto PH, Gomes AR, Aligue R et al. The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment. Mol Cancer Res 2012; 10: 1189\u20131202.","journal-title":"Mol Cancer Res"},{"key":"BFonc2015208_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/emboj.2011.434","volume":"31","author":"XX Sun","year":"2012","unstructured":"Sun XX, Challagundla KB, Dai MS . Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. EMBO J 2012; 31: 576\u2013592.","journal-title":"EMBO J"},{"key":"BFonc2015208_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/BJ20081318","volume":"418","author":"MJ Edelmann","year":"2009","unstructured":"Edelmann MJ, Iphofer A, Akutsu M, Altun M, di Gleria K, Kramer HB et al. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem J 2009; 418: 379\u2013390.","journal-title":"Biochem J"},{"key":"BFonc2015208_CR16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jmb.2008.12.085","volume":"386","author":"T Wang","year":"2009","unstructured":"Wang T, Yin L, Cooper EM, Lai MY, Dickey S, Pickart CM et al. Evidence for bidentate substrate binding as the basis for the K48 linkage specificity of otubain 1. J Mol Biol 2009; 386: 1011\u20131023.","journal-title":"J Mol Biol"},{"key":"BFonc2015208_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nature09297","volume":"466","author":"S Nakada","year":"2010","unstructured":"Nakada S, Tai I, Panier S, Al-Hakim A, Iemura S, Juang YC et al. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature 2010; 466: 941\u2013946.","journal-title":"Nature"},{"key":"BFonc2015208_CR18","doi-asserted-by":"publisher","first-page":"16135","DOI":"10.1074\/jbc.M109.007484","volume":"284","author":"V Stanisic","year":"2009","unstructured":"Stanisic V, Malovannaya A, Qin J, Lonard DM, O'Malley BW . OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity. J Biol Chem 2009; 284: 16135\u201316145.","journal-title":"J Biol Chem"},{"key":"BFonc2015208_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2010; 123: 725\u2013731.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2015208_CR20","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.2538923","volume":"243","author":"V Chau","year":"1989","unstructured":"Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989; 243: 1576\u20131583.","journal-title":"Science"},{"key":"BFonc2015208_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","volume":"78","author":"RJ Deshaies","year":"2009","unstructured":"Deshaies RJ, Joazeiro CA . RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78: 399\u2013434.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2015208_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","volume":"78","author":"D Finley","year":"2009","unstructured":"Finley D . Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 2009; 78: 477\u2013513.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2015208_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2009.01.041","volume":"137","author":"P Xu","year":"2009","unstructured":"Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009; 137: 133\u2013145.","journal-title":"Cell"},{"key":"BFonc2015208_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander D, Rape M . The ubiquitin code. Annu Rev Biochem 2012; 81: 203\u2013229.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2015208_CR25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1242\/jcs.079293","volume":"124","author":"MM Cohen","year":"2011","unstructured":"Cohen MM, Amiott EA, Day AR, Leboucher GP, Pryce EN, Glickman MH et al. Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion. J Cell Sci 2011; 124: 1403\u20131410.","journal-title":"J Cell Sci"},{"key":"BFonc2015208_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrc3120","volume":"11","author":"S Lipkowitz","year":"2011","unstructured":"Lipkowitz S, Weissman AM . RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer 2011; 11: 629\u2013643.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015208_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrm3173","volume":"12","author":"AM Weissman","year":"2011","unstructured":"Weissman AM, Shabek N, Ciechanover A . The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat Rev Mol Cell Biol 2011; 12: 605\u2013620.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2015208_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","volume":"154","author":"TE Mevissen","year":"2013","unstructured":"Mevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N et al. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 2013; 154: 169\u2013184.","journal-title":"Cell"},{"key":"BFonc2015208_CR29","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1074\/jbc.M113.533109","volume":"289","author":"Y Li","year":"2014","unstructured":"Li Y, Sun XX, Elferich J, Shinde U, David LL, Dai MS . Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein. J Biol Chem 2014; 289: 5097\u20135108.","journal-title":"J Biol Chem"},{"key":"BFonc2015208_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1476-4598-13-258","volume":"13","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X et al. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol Cancer 2014; 13: 258.","journal-title":"Mol Cancer"},{"key":"BFonc2015208_CR31","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.prp.2014.05.008","volume":"210","author":"X Liu","year":"2014","unstructured":"Liu X, Jiang WN, Wang JG, Chen H . Colon cancer bears overexpression of OTUB1. Pathol Res Pract 2014; 210: 770\u2013773.","journal-title":"Pathol Res Pract"},{"key":"BFonc2015208_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-014-0280-2","volume":"14","author":"D Iglesias-Gato","year":"2015","unstructured":"Iglesias-Gato D, Chuan YC, Jiang N, Svensson C, Bao J, Paul I et al. OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo. Mol Cancer 2015; 14: 8.","journal-title":"Mol Cancer"},{"key":"BFonc2015208_CR33","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.steroids.2008.04.006","volume":"73","author":"EM Fox","year":"2008","unstructured":"Fox EM, Davis RJ, Shupnik MA . ERbeta in breast cancer\u2014onlooker, passive player, or active protector? Steroids 2008; 73: 1039\u20131051.","journal-title":"Steroids"},{"key":"BFonc2015208_CR34","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni JF Jr., Nelson CE, Kim DH et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233\u20131238.","journal-title":"Science"},{"key":"BFonc2015208_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/BF00202481","volume":"90","author":"S Singh","year":"1993","unstructured":"Singh S, Simon M, Meybohm I, Jantke I, Jonat W, Maass H et al. Human breast cancer: frequent p53 allele loss and protein overexpression. Hum Genet 1993; 90: 635\u2013640.","journal-title":"Hum Genet"},{"key":"BFonc2015208_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/emboj\/18.3.717","volume":"18","author":"SE Salghetti","year":"1999","unstructured":"Salghetti SE, Kim SY, Tansey WP . Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 1999; 18: 717\u2013726.","journal-title":"EMBO J"},{"key":"BFonc2015208_CR37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/1535-7163.MCT-07-0397","volume":"7","author":"RC Hui","year":"2008","unstructured":"Hui RC, Francis RE, Guest SK, Costa JR, Gomes AR, Myatt SS et al. Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells. Mol Cancer Ther 2008; 7: 670\u2013678.","journal-title":"Mol Cancer Ther"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2015208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2015208","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2015208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:58:22Z","timestamp":1684472302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFonc2015208"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.208","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]},"assertion":[{"value":"27 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}